27 November 2024
27 November 2024
The trial, named CONVOY, will operate with cross-enrolling from the ongoing PRIME study in the US.
With the expanded partnership, Philips aims to advance its HealthSuite cloud services and power genAI workflows.
The system is set to offer a set of advanced tools to balance diagnostic accuracy with rapid workflows.
The company anticipates introducing its fingerprint sweat-based drug screening technology by next year.
The acquisition marks Arlington’s latest investment out of its $3.8bn VI Fund.
The BrioVAD System is a full-support, durable ventricular assist device designed to enhance the quality of life in patients.
Freedom Laser Therapy is based in the U.S. and a Dual Category Award Winner in the 2024 Medical Device Network Excellence Awards
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
